Suppliers / Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda

Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda

Brazil Updated 9 July 2026

The public registers hold a second record for Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda. The fuller profile, with 34 active US DMFs and 33 valid CEPs, is at Ajinomoto. Figures on this page cover only this record.

Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda is an API manufacturer based in Brazil. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 11 August 2023 as VAI.

2
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 11 August 2023 VAI US FDA
  • 15 December 2017 VAI US FDA
  • 7 November 2014 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Brazil, Brazil 1000508879

What they file, and where

Molecule Regulators Docs
Isoleucine US FDA 1
L-Glutamine US FDA 1

Also appears on these molecule pages

Isoleucine API L-Glutamine API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda

Does Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda hold a US DMF or a CEP?
Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda FDA-registered?
One site operated by Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda's last inspection go?
The most recent inspection on record closed on 11 August 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 3 inspections are on file.
Where does Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda manufacture?
1 registered site is on record, in Brazil (Brazil). Every site is listed on this page with the register it came from.
What does Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda make?
2 molecules are on record against Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda, including Isoleucine and L-Glutamine. Each links through to that molecule's full manufacturer list.
Which regulators recognise Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Ajinomoto Do Brazil Industria E Comercio de Alimentos Ltda comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 11 August 2023.

Comparable suppliers

Biophore India Pharmaceuticals shares 1 molecule Honour Lab shares 1 molecule Ajinomoto shares 1 molecule Ss Pharma shares 1 molecule Mianyang Shengshi Health Technology shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates